Delivery Order SPE2DB25D3012-SPE2DB25FWYPB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 1, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency awarded a $2,228.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of June 24, 2025. This non-set-aside contract was competitively awarded on June 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is a corticosteroid injectable medication used for intra-articular injection to treat osteoarthritis pain, representing part of...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with a firm fixed price and no set-aside designation. The order, placed under a competitive award process, is scheduled for completion by September 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a ceiling value of $7,429.80. This is a firm fixed price delivery order with an ultimate completion date of June 25, 2025, awarded on June 3, 2025, and involves no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,485.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 8, 2025. This non-set-aside contract was competitively awarded on September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing a specialized pharmaceutical product...
- The Defense Logistics Agency awarded a $3,714.90 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract awarded on July 22, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, indicating this procurement supports military healthcare needs for pain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials valued at $2,228.94 with a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular corticosteroid injection used for pain management in joint conditions, representing part of the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,228.94 by the Defense Logistics Agency on June 16, 2025, for the supply of Zilretta 32 mg vials. The contract is a firm fixed-price delivery order with an ultimate completion date of July 9, 2025, and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYPBDelivery Order
The Defense Logistics Agency awarded a $7,429.80 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Zilretta 32 mg vials, with completion targeted for August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. Zilretta is an intra-articular corticosteroid injection used for pain management in joint conditions, reflecting AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement. As a major healthcare solutions provider and one of the nation's leading pharmaceutical distributors, AmerisourceBergen supplies a broad portfolio of medications and medical commodities—including specialty pharmaceuticals, brand-name and generic drugs, and medical devices—across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record of competitively awarded contracts demonstrates its capability to meet stringent federal procurement requirements and support the military's comprehensive healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 7/11/25 |